WallStSmart

Basel Medical Group Ltd Ordinary Shares (BMGL)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 35690% more annual revenue ($5.27B vs $14.74M). ENSG leads profitability with a 6.9% profit margin vs -68.2%. ENSG earns a higher WallStSmart Score of 62/100 (C+).

BMGL

Hold

38

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 3/9Altman Z: -1.69

ENSG

Buy

62

out of 100

Grade: C+

Growth: 8.0Profit: 6.0Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 2.15
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BMGL.

ENSGSignificantly Overvalued (-45.8%)

Margin of Safety

-45.8%

Fair Value

$145.31

Current Price

$178.83

$33.52 premium

UndervaluedFair: $145.31Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BMGL2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
67.1%10/10

Revenue surging 67.1% year-over-year

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

ENSG2 strengths · Avg: 8.0/10
Revenue GrowthGrowth
18.4%8/10

18.4% revenue growth

EPS GrowthGrowth
21.9%8/10

Earnings expanding 21.9% YoY

Areas to Watch

BMGL4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$8.80M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.573/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.514/10

Expensive relative to growth rate

P/E RatioValuation
27.9x4/10

Moderate valuation

Profit MarginProfitability
6.9%3/10

6.9% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : BMGL

The strongest argument for BMGL centers on Revenue Growth, Price/Book. Revenue growth of 67.1% demonstrates continued momentum.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth, EPS Growth. Revenue growth of 18.4% demonstrates continued momentum.

Bear Case : BMGL

The primary concerns for BMGL are EPS Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.57 is elevated, increasing financial risk.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Key Dynamics to Monitor

BMGL profiles as a hypergrowth stock while ENSG is a growth play — different risk/reward profiles.

BMGL is growing revenue faster at 67.1% — sustainability is the question.

ENSG generates stronger free cash flow (119M), providing more financial flexibility.

Monitor MEDICAL CARE FACILITIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ENSG scores higher overall (62/100 vs 38/100) and 18.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Basel Medical Group Ltd Ordinary Shares

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Basel Medical Group Ltd provides healthcare services. The company is headquartered in Singapore.

Visit Website →

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?